(Q41615181)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086382%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086382%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086382%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Craft N

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086382%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Shostak Y

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086382%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Sawyers CL

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086382%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086382%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086382%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086382%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

280-285

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086382%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086382%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/6495

12 November 2019

exact match

0 references

cites work

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

1 reference

7 January 2021

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

1 reference

7 January 2021

The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens

1 reference

7 January 2021

Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor

1 reference

7 January 2021

Dopaminergic and Ligand-Independent Activation of Steroid Hormone Receptors

1 reference

7 January 2021

Regulation of progesterone receptor-mediated transcription by phosphorylation

1 reference

7 January 2021

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

7 January 2021

ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer

1 reference

7 January 2021

Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.

1 reference

7 January 2021

Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate

1 reference

7 January 2021

A tyrosine kinase profile of prostate carcinoma

1 reference

7 January 2021

p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate

1 reference

7 January 2021

Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer

1 reference

7 January 2021

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma

1 reference

7 January 2021

c-erbB-2 oncoprotein: a potential biomarker of advanced prostate cancer

1 reference

7 January 2021

Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice

1 reference

7 January 2021

Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects.

1 reference

7 January 2021

An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter

1 reference

7 January 2021

Prostate-specific antigen expression is regulated by an upstream enhancer

1 reference

7 January 2021

TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins

1 reference

7 January 2021

The promoter of the prostate-specific antigen gene contains a functional androgen responsive element

1 reference

7 January 2021

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

7 January 2021

Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo

1 reference

7 January 2021

A growing coactivator network

1 reference

7 January 2021

Nuclear receptor coactivators

1 reference

7 January 2021

A synergistic increase in potency of a multimerized VP16 transcriptional activation domain

1 reference

7 January 2021

The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation

1 reference

7 January 2021

Identifiers

DOI

10.1038/6495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086382%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference